THYROCARENSEThyrocare Technologies LimitedMediumNeutral
Announced Fri, 5 Jun · 12:39 IST

Docon Technologies Private Ltd has submitted to  the Exchange a copy of disclosure under Regulations, 31(1) and 31(2) of SEBI ( SAST) Regulations, 2011.

Ownership Changes View source PDF

THYROCARE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+4.4%1-day move
₹516.80
prior close
₹518.80
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1-0.4-0.1-0.2+4.4+6.2+3.3+1.2+2.9+3.7+1.6+5.1
Up moveDown movePending
AI summary

Docon Technologies Private Ltd, which is part of the promoter group of Thyrocare Technologies, has submitted a disclosure to the stock exchange under Regulations 31(1) and 31(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. These regulations require disclosures related to shareholding of the acquirer along with persons acting in concert. The filing itself is procedural in nature and indicates a change in shareholding that has triggered the disclosure requirement. Specific details on the exact change — whether it is an increase or decrease and the percentage involved — are not provided in this headline.

Likely market impact

The announcement is primarily a regulatory compliance filing, so direct impact on the stock price is limited. Investors should watch for further details on whether the promoter group's stake has changed materially, as any significant increase or decrease in promoter holding could affect sentiment.